Gabbai Daniel, Gilboa Itamar, Lavie Anat, Yogev Yariv, Attali Emmanuel
Lis Hospital for Women's Health, Tel Aviv Sourasky Medical Center, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
O G Open. 2025 Aug 14;2(4):e108. doi: 10.1097/og9.0000000000000108. eCollection 2025 Aug.
To compare the efficacy of two antibiotic regimens (cefazolin vs clindamycin plus gentamicin) for preventing infectious complications after planned cesarean delivery.
A retrospective cohort study was conducted at a tertiary university-affiliated medical center between 2012 and 2023. All women undergoing planned cesarean delivery were included and divided into two groups: The standard regimen group (control) was treated with cefazolin, and the study group, consisting of women with reported severe penicillin allergies or cephalosporin allergies, was treated with a clindamycin plus gentamicin regimen. Maternal and neonatal outcomes were analyzed with multivariate logistic regression. The primary outcome was the need for inpatient antibiotic treatment; the secondary outcome was readmission for obstetric or gynecologic complications.
During the study period, 145,883 deliveries occurred in our department, of which 17,693 (12.1%) were by planned cesarean deliveries. Among these, 10,588 women (94.1%) received cefazolin, and 658 women (5.9%) received clindamycin plus gentamicin. Infectious complications were less frequent in the control group. The need for inpatient antibiotic treatment was 5.9% in the cefazolin group compared with 15.2% in the clindamycin plus gentamicin group (<.001), and readmission rates were 1.8% vs 3.8%, respectively (=.001). On multivariate analysis, the alternative regimen group had significantly higher odds of requiring inpatient antibiotics after cesarean delivery (adjusted odds ratio [aOR] 2.1, 95% CI, 1.54-2.80, <.001) and readmission (aOR 1.95, 95% CI, 1.19-3.18, =.008).
Cefazolin may be more effective than clindamycin plus gentamicin in preventing infectious complications after planned cesarean delivery. This study emphasizes the importance of careful assessment of β-lactam allergies to guide optimal antibiotic choices. For women allergic to standard regimens, alternative strategies should be considered to reduce postoperative infections and complications.
比较两种抗生素方案(头孢唑林与克林霉素加庆大霉素)在预防择期剖宫产术后感染性并发症方面的疗效。
在一所大学附属三级医疗中心于2012年至2023年进行了一项回顾性队列研究。纳入所有接受择期剖宫产的女性,并将其分为两组:标准方案组(对照组)接受头孢唑林治疗,研究组由报告有严重青霉素过敏或头孢菌素过敏的女性组成,接受克林霉素加庆大霉素方案治疗。采用多因素逻辑回归分析母婴结局。主要结局是住院期间抗生素治疗的必要性;次要结局是因产科或妇科并发症再次入院。
在研究期间,我院共分娩145,883例,其中17,693例(12.1%)为择期剖宫产。其中,10,588名女性(94.1%)接受了头孢唑林治疗,658名女性(5.9%)接受了克林霉素加庆大霉素治疗。对照组感染性并发症较少见。头孢唑林组住院期间抗生素治疗的必要性为5.9%,而克林霉素加庆大霉素组为15.2%(<.001),再次入院率分别为1.8%和3.8%(=.001)。多因素分析显示,替代方案组剖宫产术后需要住院使用抗生素的几率显著更高(调整优势比[aOR] 2.1,95%可信区间[CI],1.54 - 2.80,<.001)以及再次入院几率(aOR 1.95,95% CI,1.19 - 3.18,=.008)。
在预防择期剖宫产术后感染性并发症方面,头孢唑林可能比克林霉素加庆大霉素更有效。本研究强调了仔细评估β-内酰胺类过敏以指导最佳抗生素选择的重要性。对于对标准方案过敏的女性,应考虑采用替代策略以减少术后感染和并发症。